Bayer says $2.6bn Algeta takeover successful

Bayer says $2.6bn Algeta takeover successful

German pharmaceuticals giant Bayer said on Wednesday that its 1.9-billion-euro ($2.6-billion) bid for Norwegian cancer treatment specialist Algeta has been successful and it now holds more than 97 percent in the firm.

Bayer bids $2.4bn for Norway pharma firm

Bayer bids $2.4bn for Norway pharma firm